» Articles » PMID: 24817030

Helmet CPAP Vs. Oxygen Therapy in Severe Hypoxemic Respiratory Failure Due to Pneumonia

Overview
Specialty Critical Care
Date 2014 May 13
PMID 24817030
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The efficacy of noninvasive continuous positive airway pressure (CPAP) to improve outcomes in severe hypoxemic acute respiratory failure (hARF) due to pneumonia has not been clearly established. The aim of this study was to compare CPAP vs. oxygen therapy to reduce the risk of meeting criteria for endotracheal intubation (ETI).

Methods: In a multicenter randomized controlled trial conducted in four Italian centers patients with severe hARF due to pneumonia were randomized to receive helmet CPAP (CPAP group) or oxygen delivered with a Venturi mask (control group). The primary endpoint was the percentage of patients meeting criteria for ETI, including either one or more major criteria (respiratory arrest, respiratory pauses with unconsciousness, severe hemodynamic instability, intolerance) or at least two minor criteria (reduction of at least 30% of basal PaO2/FiO2 ratio, increase of 20% of PaCO2, worsening of alertness, respiratory distress, SpO2 less than 90%, exhaustion).

Results: Between February 2010 and 2013, 40 patients were randomized to CPAP and 41 to Venturi mask. The proportion of patients meeting ETI criteria in the CPAP group was significantly lower compared to those in the control group (6/40 = 15% vs. 26/41 = 63%, respectively, p < 0.001; relative risk 0.24, 95% CI 0.11-0.51; number needed to treat, 2) two patients were intubated in the CPAP group and one in the control group. The CPAP group showed a faster and greater improvement in oxygenation in comparison to controls (p < 0.001). In either study group, no relevant adverse events were detected.

Conclusions: Helmet CPAP reduces the risk of meeting ETI criteria compared to oxygen therapy in patients with severe hARF due to pneumonia.

Citing Articles

Preoxygenation strategies before intubation in patients with acute hypoxic respiratory failure: a network meta-analysis.

Ye N, Wei C, Deng J, Wang Y, Xie H Front Med (Lausanne). 2025; 12:1532911.

PMID: 39995692 PMC: 11847861. DOI: 10.3389/fmed.2025.1532911.


Comparison of the effectiveness of the helmet interface using flow meters versus the mechanical ventilator for non-invasive ventilation in patients with coronavirus disease 2019. Controlled and randomized clinical trial.

Dos Reis Ferreira F, Correa J, Storopoli E, Faria D, Cassaro K, Feitosa da Hora N Arch Med Sci. 2024; 20(5):1538-1546.

PMID: 39649277 PMC: 11623150. DOI: 10.5114/aoms/183947.


Oxygen therapy and noninvasive respiratory supports in acute hypoxemic respiratory failure: a narrative review.

Thille A, Balen F, Carteaux G, Chouihed T, Frat J, Girault C Ann Intensive Care. 2024; 14(1):158.

PMID: 39419924 PMC: 11486880. DOI: 10.1186/s13613-024-01389-w.


Oxygen therapy in acute hypoxemic respiratory failure: guidelines from the SRLF-SFMU consensus conference.

Helms J, Catoire P, Abensur Vuillaume L, Bannelier H, Douillet D, Dupuis C Ann Intensive Care. 2024; 14(1):140.

PMID: 39235690 PMC: 11377397. DOI: 10.1186/s13613-024-01367-2.


The "ZEEP-PEEP test" to evaluate the response to positive end-expiratory pressure delivered by helmet: A prospective physiologic study.

Giani M, Fumagalli B, Cipulli F, Rezoagli E, Pozzi M, Fumagalli D Heliyon. 2024; 10(6):e28339.

PMID: 38524568 PMC: 10957420. DOI: 10.1016/j.heliyon.2024.e28339.


References
1.
Delclaux C, LHer E, Alberti C, Mancebo J, Abroug F, Conti G . Treatment of acute hypoxemic nonhypercapnic respiratory insufficiency with continuous positive airway pressure delivered by a face mask: A randomized controlled trial. JAMA. 2000; 284(18):2352-60. DOI: 10.1001/jama.284.18.2352. View

2.
Squadrone V, Coha M, Cerutti E, Schellino M, Biolino P, Occella P . Continuous positive airway pressure for treatment of postoperative hypoxemia: a randomized controlled trial. JAMA. 2005; 293(5):589-95. DOI: 10.1001/jama.293.5.589. View

3.
Fine M, Auble T, Yealy D, Hanusa B, Weissfeld L, Singer D . A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997; 336(4):243-50. DOI: 10.1056/NEJM199701233360402. View

4.
Mandell L, Wunderink R, Anzueto A, Bartlett J, Campbell G, Dean N . Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007; 44 Suppl 2:S27-72. PMC: 7107997. DOI: 10.1086/511159. View

5.
. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005; 171(4):388-416. DOI: 10.1164/rccm.200405-644ST. View